213 related articles for article (PubMed ID: 19885577)
1. Genetic and molecular alterations associated with oral squamous cell cancer (Review).
Pérez-Sayáns M; Somoza-Martín JM; Barros-Angueira F; Reboiras-López MD; Gándara Rey JM; García-García A
Oncol Rep; 2009 Dec; 22(6):1277-82. PubMed ID: 19885577
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.
Choi S; Myers JN
J Dent Res; 2008 Jan; 87(1):14-32. PubMed ID: 18096889
[TBL] [Abstract][Full Text] [Related]
3. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
5. Genetic etiology of oral cancer.
Ali J; Sabiha B; Jan HU; Haider SA; Khan AA; Ali SS
Oral Oncol; 2017 Jul; 70():23-28. PubMed ID: 28622887
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of oral squamous carcinoma.
Williams HK
Mol Pathol; 2000 Aug; 53(4):165-72. PubMed ID: 11040937
[TBL] [Abstract][Full Text] [Related]
7. Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.
Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
J Exp Clin Cancer Res; 2016 Jun; 35(1):92. PubMed ID: 27297407
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.
Towle R; Truong D; Garnis C
Genes Chromosomes Cancer; 2016 Jul; 55(7):568-76. PubMed ID: 27015871
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.
Lee CH; Wong TS; Chan JY; Lu SC; Lin P; Cheng AJ; Chen YJ; Chang JS; Hsiao SH; Leu YW; Li CI; Hsiao JR; Chang JY
J Pathol; 2013 Jul; 230(3):298-309. PubMed ID: 23362108
[TBL] [Abstract][Full Text] [Related]
10. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
12. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma.
Naganuma K; Hatta M; Ikebe T; Yamazaki J
BMC Cancer; 2014 Dec; 14():988. PubMed ID: 25527207
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of oral cavity squamous cell carcinoma.
Kupferman ME; Myers JN
Otolaryngol Clin North Am; 2006 Apr; 39(2):229-47. PubMed ID: 16580909
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic disregulation in oral cancer.
Mascolo M; Siano M; Ilardi G; Russo D; Merolla F; Rosa G; Staibano S
Int J Mol Sci; 2012; 13(2):2331-2353. PubMed ID: 22408457
[TBL] [Abstract][Full Text] [Related]
17. 3-Deazaneplanocin A suppresses aggressive phenotype-related gene expression in an oral squamous cell carcinoma cell line.
Hatta M; Naganuma K; Kato K; Yamazaki J
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):269-73. PubMed ID: 26505792
[TBL] [Abstract][Full Text] [Related]
18. Oncogenes, tumor suppressors and viruses in oral squamous carcinoma.
Scully C
J Oral Pathol Med; 1993 Sep; 22(8):337-47. PubMed ID: 8283399
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
20. p16(INK4a)/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?
Pérez-Sayáns M; Suárez-Peñaranda JM; Gayoso-Diz P; Barros-Angueira F; Gándara-Rey JM; García-García A
Cancer Lett; 2011 Jul; 306(2):134-41. PubMed ID: 21411222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
